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Postsynthetic Stille cross-coupling for functionalization of oligonucleotides on solid support was applied
on iodo modiﬁed RNA utilizing different protecting group strategies. As result, the otherwise very suc-
cessful ACE [bis(acetoxyethyloxy)-methyl orthoester] chemistry was found to be limited since methyl-
ated side-products formed as was investigated via enzymatic degradation of RNA and various monomer
model reactions. Enzymatic digestion of poly uridine sequences revealed presence of considerable
amounts of N3-methylated uridine derivatives due to migration of methyl as phosphate protecting group
used in ACE strategy. Monomer test reactions mimicking conditions on RNA clearly indicated an en-
hanced methylation effect correlated to the Stille coupling procedure.
 2013 The Authors. Published by Elsevier Ltd.Open access under CC BY-NC-ND license. 1. Introduction
Modiﬁed oligonucleotides, and in particular, labeled RNA, rep-
resent valuable tools in biochemical andmedicinal research and are
extensively applied for analytical and therapeutic purposes.1e3
Hence, there is a growing demand in synthesis of oligonucleo-
tides and efﬁcient introduction of speciﬁc labels to obtain desired
functionalized nucleic acid compounds.4,5
In general, chemical derivatization of synthetic oligonucleotides
can be achieved via insertion of modiﬁed phosphoramidites during
solid phase synthesis or by postsynthetic approaches.5 The last-
mentioned concept is non-linear and proﬁts from greater ﬂexibil-
ity in regard to using different labels eventually. There are several
reports on postsynthetic methods on DNA, e.g., reviewed by Marx
et al.,4 and also few on RNA, recently discussed by us.6
Obviously, an effective automated RNA synthesis in high yields
is a general prerequisite for postsynthetic derivatization. It is
a widely accepted fact that RNA synthesis is more challenging
compared to DNA synthesisdlower coupling efﬁciency in thex: þ49 69 79829148; e-mail
e, joachim.engels@me.com
r Ltd. Open access under CC BY-NC-NDsynthesis cycle as well as the necessity to permanently block the 20-
hydroxyl function complicates the setup for RNA.7e9 The most
commonly used protecting group strategy consists of the ‘classical’
TBDMS10,11 (tert-butyldimethylsilyl) approach, which can also in-
volve alternative utilization of 20-O-TOM12,13 (triisopropylsilylox-
ymethyl) groups resulting in reduced steric hindrance, and thus, in
increased coupling rates. This, as well as the emergence of ACE14,15
chemistry in the ﬁrst instance,5,16 and of lately developed TC17 (1,1-
dioxo-1l6-thiomorpholine-4-carbothioate) strategy, too, are de-
scribed to improve the outcome in RNA synthesis. Actually, these
advances are reported to render automated RNA synthesis almost
as reliable as DNA synthesis.14,17
Selection of the labeling reaction for postsynthetic de-
rivatization on-column, which beneﬁts from advantages in solid
phase synthesis, such as high yields and ease in separation and
puriﬁcation, is dependent on compatibility with RNA stability, solid
support conditions and chosen protecting group chemistry.
Our group is interested in postsynthetic palladium-catalyzed
reactions on oligonucleotides in general. While Sonogashira
cross-couplings on-column on DNA have been ﬁrst reported by
Grinstaff and Khan,18 followed byWagenknecht et al.19 and us,20e22
we pioneered the application also on RNA22e26 employing TBDMS
as well as ACE protection strategies.
Recently, we further expanded our on column concept for
postsynthetic derivatization on RNA to Stille cross-coupling and
could show the versatility of our new method.6 Therein, function-
alization by Stille reactions was performed on iodo modiﬁed license. 
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TBDMS, ACE14 and TC17 protecting group strategies, and trans-
formation of the iodo function (in terms of complete conversion) to
attach the desired label was found to be successful independently
of applied chemistry.
However, remarkable differences in exclusive product forma-
tion, yield, purity, and efﬁciency could be observed, and herein
results particularly referring to ACE chemistry are reported in more
detail.2. Results and discussion
2.1. Stille cross-couplings on RNA synthesized via TBDMS, TC,
and ACE chemistry
Most experiments were carried out with commonly used
TBDMS-protected RNA (ON 1, compare Table 1) that is bound to cpg
(controlled pore glass) solid phase materialdthis turned out to be
fully compatible with conditions of Stille cross-coupling, and
completely converted RNA was isolated in yields comparable to
unmodiﬁed oligonucleotides.6Table 1
RNA oligonucleotides discussed within this manuscripta
Name Sequence Comment
ON 1 50-UUU UUU U*UU UU Via TBDMS chemistry, furyl-modiﬁed
ON 2 50-UUU UUU U*UU UUU Via TC chemistry, furyl-modiﬁed
ON 3 50-UUU UUU U*UU UUU Via ACE chemistry, furyl-modiﬁed
ON 4 50-UUU UUU UUU UUU Unmodiﬁed, for control purposes
ON 5b 50-UUU UUU U*UU UUU Via ACE chemistry, furyl-modiﬁed
a Synthesis, postsynthetic derivatization by Stille coupling, puriﬁcation and
characterization of ON 1eON 3 have been reported before.6
b Modiﬁed procedure: a converted order in deprotection and postsynthetic
functionalization was employed, ﬁrst removal of methyl protecting groups and af-
terward Stille coupling was carried out on bead.Furthermore, we applied an initial experiment on Stille de-
rivatization by employing TC chemistry, a protecting group strategy
newly developed by Caruthers et al.17 Similarly to TBDMS strategy,
TC protecting group chemistry is based on use of 50-O-dimethox-
ytrityl (DMTr), b-cyanoethyl for the phosphate and standard
nucleobase protection as well as cpg as solid support allowing an
almost identical setup for automated RNA synthesis. Instead of
TBDMS, TC is utilized as 20-O protecting group permitting a single-
step basic deprotection using ethylenediamine under anhydrous
conditions.17 To the best of our knowledge, we pioneered the ap-
plication of TC strategy in synthesis of modiﬁed RNA.6 As described
before, Stille cross-coupling was found to be fully compatible and
ON 2 had been completely converted to desired furyl-modiﬁed RNA
in excellent yield and very high purity.6 Formation of breakdown
sequences was in case of TC protected RNA greatly diminished in-
dicating high coupling efﬁciency. Thus, higher quantity of desired
12-mer could be isolated in comparison to TBDMS chemistry
(compare to AE HPLC chromatograms in Fig. S1, Supplementary
data). Besides integration of the chromatograms, this observation
was conﬁrmed in isolated amounts of modiﬁed RNA, too. Never-
theless, this is not due to applicability of Stille cross-coupling but
rather attributed to differences in automated RNA synthesis,
deprotection and isolation steps for TBDMS or for TC chemistry; as
can be seen in RP HPLC chromatograms (Fig. S1, Supplementary
data), transformation to furyl-coupled product had been over 90%
for both strategies.
However, our excellent experiences with ACE chemistry, espe-
cially in combination with post-synthetic Sonogashira cross-cou-
plings,24 led us to test ACE protected RNA, immobilized on
polystyrene support also for Stille cross-couplings.6 Generally, ACEstrategy provides a completely different approach requiring alter-
ation of instrumentation since not acid-labile 50-DMTr but ﬂuoride-
labile 50-BzH [bis(trimethylsilyloxy)benzhydryloxysilyl] is used in
combination with an acid-labile 20-O orthoester. As consequence,
no ﬂuoride-sensitive cpg can be used as solid phase material but
polystyrene support must be employed. For the same reason, cya-
noethyl, which might be cleaved by ﬂuoride, too, is substituted by
methyl as phosphate protecting group.
Conform to studies with Sonogashira cross-couplings; high-
yielded modiﬁed RNA (ON 3, Table 1) could be isolated. Coupling
efﬁciency in automated oligonucleotide synthesis is very high for
ACE chemistry (yields are described14 to be so excellent that the
only disadvantage, the lack of trityl monitor, is of no consequence).
Preparation of ACE protected modiﬁed phosphoramidites, such as
iodo nucleotides gives high yields and is very convenient. Particu-
larly, no 20, 30-regioisomermixtures being often observed in TBDMS
chemistry form during the 20-O blocking step. Moreover, the ad-
ditional work-up procedure is less time-consuming, and being
more practical in respect to handling under conditions not neces-
sarily sterile, ACE strategy emerged as the most advantageous ap-
proach in our hands so far.
Nevertheless, poly uridine 12-mer oligonucleotide synthesized
via ACE chemistry (ON 3) was separated from shorter failure se-
quences on anion exchange HPLC, desalted on Sephadex G25 ma-
terial, and analyzed by mass spectrometry providing a surprising
result. Crude ON 3 showed besides desired mass an unexpected
pattern with a series of additional þ14 signals (see Fig. 1A).
An analytical sample of ON 3 to RP HPLC also manifested the
presence of several compounds (compare to Fig. 1B).
We supposed there might be a connection to the methyl group
that is used as phosphate protecting group in ACE chemistry. We
excluded incomplete methyl group removal after synthesis and
derivatization since this would have been detected on anion ex-
change HPLC. Thus, methyl group transfer from the oligonucleotide
backbone to the base residue seems to be due to conditions of Stille
cross-couplings resulting in methylated uridine species.
In fact, methyl as phosphate protecting group provides a triester
phosphate carrying two sugar residues and one methyl group, and
thus resembles the alkylating agent TMP (trimethylphosphate). In
various studies, conversion with TMP particularly under aqueous
conditions turned out to be rather efﬁcient in methylation of N1/N3
pyrimidines27,28 and N1/N3 N7/N9 purines27,29 as well as for N3
pyrimidine and N1/N6 purine ribo- and deoxyribonucleosides30e33
and also on nucleotides33, respectively. Since for methylation with
TMP only one methyl group is offered and dimethylhy-
drogenphosphate forms,30 the methyl protected phosphate back-
bone could be a mimetic and also cause methylation.
Furthermore, methylation of thymine residues during oligonu-
cleotide synthesis was already earlier reported by Jones.34 The
authors claim that thymine residues are subjected tomethylation at
N3 via internucleotide methyl phosphotriester linkages. They per-
formed model reactions with thymidine monomers, dimers, and
hexamers in the presence of bases, such as DBU (1,8-diazabicyclo
[5.4.0]undec-7-ene) or TEA (triethylamine) observing N-methyla-
tion and concluding that thymidine alkylation is a potential side
reaction during oligonucleotide synthesis and deprotection steps.
Actually, they found these impurities in small amounts indicating
methylation processes. Nevertheless, they note that the extent of
alkylation can be minimized by avoiding strong bases and concede
that the small amount of methylated material might have no de-
tectable effect for most applications.34
This might clarify why Scaringe et al.14 claim in their original
presentation about ACE strategy that no side-products could be
detected supporting this by anion exchange HPLC chromatograms
but without mass spectra. However, Jones et al.34 observed the
methylation side reaction via RP HPLC for DNA standard synthesis
Fig. 1. ESI()-mass spectrum (A) and RP HPLC chromatogram (B) of poly uridine 12-mer RNA ON 3 synthesized via ACE strategy and postsynthetically furyl-labeled via Stille cross-
coupling: besides desired product also methylated species (þ14) could be detected.
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protecting group). Even in our hands we could detect methylated
uridines on RP HPLC but not on anion exchange columns. Although
no base is used in Stille cross-coupling, same effect of methylation
(such as described by Jones et al.34) occurred in high degree
heredRP HPLC and mass spectra showed not just traces of meth-
ylated material but approximately identical quantities for each of
the four species (Fig. 1A and B).
2.2. Studies of methylation processes on RNA caused by Stille
coupling
To further investigate this phenomenon, we ﬁrst proved the
presence of methylated uridine nucleosides. For this purpose, en-
zymatic digestion of the oligonucleotide was performed to allow
subsequent analysis of free nucleosides. Moreover, the second ob-
jective involved test reactions on monomers based on conditions of
Stille cross-coupling on RNAdtherefore, high excess of reagents
and addition of TMP were applied to mimic the protected phos-
phate backbone in RNA.
RNA oligonucleotides were degraded to free nucleosides by
enzymatic digestion with endonuclease P1 followed by alkaline
phosphatase for dephosphorylation. This was performed with poly
uridine 12-mer ON 3 that had been furyl-modiﬁed via Stille cross-
coupling and being characterized as mixture of desired product
and several species with additional þ14 masses (compare to Fig. 1).
As control experiment, completely unmodiﬁed 12-mer poly uridine
ON 4 was also subjected to enzymatic digestion. Analysis of
digested oligonucleotides was performed via analytical RP HPLC.
We supposed that base composition analysis of furyl-modiﬁed poly
uridine 12-mer ON 3 would reveal not only uridine 1 and 5-furyl
uridine 3 but additionally N-methyl uridine 2 and 5-furyl-N-
methyl uridine 4 (Fig. 2).
Signals from digested RNA, which was directly subjected to RP
HPLC, could be assigned via comparison to reference chromato-
grams of monomer compounds 1e4; and additionally, peaks were
collected and conﬁrmed by mass spectrometry analysis. In fact,
digestion of unmodiﬁed 12-mer ON 4 as control experiment
showed the expected single peak of natural uridine (not shown);and for the examined furyl-modiﬁed 12-mer ON 3 predicted uri-
dine derivatives 1-4were found, and thus, formation of methylated
species was proven (see Fig. 2).
After enzymatic digestion, all four uridine species were detected
indicating that no complete methylation of all 5-furyl uridine
building blocks occurred, but rather a kind of statistic distribution
for methylation process seems to happen. However, it is striking
that probability of methylation for 5-furyl uridine seems to be
highly increased compared to uridine (integral ratio in HPLC
chromatogram: 5-furyl N-methyl uridine 4 to 5-furyl uridine 3 one
order of magnitude higher than N-methyl uridine 2 to uridine 1,
compare to Fig. 2). This observation could be conﬁrmed in studies
concerning monomer tests that are described below and is proba-
bly due to higher reactivity of 5-furyl uridine towards electrophiles
(compare to Section 2.3).
Monomer model reactions that were intended to simulate the
setting for Stille cross-coupling on RNA, were carried out with
uridine 1, 5-iodo uridine 5, or a mixture of both, respectively. The
nucleosides were treated with TMP mimicking the methyl phos-
phate backbone under different setups involving Stille coupling
conditions (Scheme 1, and compare to Table 2).
For that purpose, we monitored all test reactions by analytical
RP HPLC.
First experiments using 1 equiv TMP and stirring at room tem-
perature or at 60 C showed that no transformation of uridine 1
(Table 2, exp. no. 1, 2, 5, 6, and 9) could be achieved independently
of adding organotributylstannane or increasing the catalyst/ligand
loading.
Model reactions on 5-iodo uridine 5 (exp. no. 3, 4, 7, 8, and 10)
revealed that addition of tributylfuryl stannane is obligatory to
mediate the methylation side reaction. That indicates that meth-
ylation cannot be explained by the only presence of catalyst and
ligand even if palladium and ligand complexing the nucleoside
might support the process. Particular conditions (exp. no. 3, 7, and
10) led to complete conversion of 5-iodo uridine 5 to 5-furyl uri-
dine 3, and methylation resulting in N-methyl 5-furyl uridine 4
could be detected. Besides analysis by analytical RP HPLC, one
testing (exp. no. 7) was additionally worked-up and puriﬁed via
column chromatography permitting not only mass spectrometry
Scheme 1. Monomer test reactions to mimic Stille cross-coupling under RNA conditions for examination of N-methylation (particular settings are given in Table 2).
Fig. 2. RP HPLC chromatogram of furyl-modiﬁed uridine 12-mer ON 3 (synthesized via ACE chemistry) after enzymatic digestion: monomeric uridine derivatives 1e4 were
monitored.
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compounds as 3 and 4. Conform to relations determined via in-
tegration of HPLC signals (compare Table 2, exp. no. 7), 37.5% 5-
furyl uridine 3 and 62.5% N-methyl 5-furyl uridine 4 were iso-
lated as pure compounds.
We further investigated the role of the catalytic cycle in regard
to the fact that uridine alone seems not to get methylated in the test
reactions (so far, exclusive methylation of furyl uridine 3 emerged
what might be due to electronic and thus reactivity reasons;
compare to results of oligonucleotide digestion, in which the
amount of methylated uridine 2 formed in lesser extent than
methylated furyl uridine 4). The next experiment (exp. no. 11)
consisted of employing both nucleosides uridine 1 and 5-iodo
uridine 5 as they are coexisting in the oligonucleotide. Finally,
considering the much higher reaction rate of intrastrand reactions
and motivated by the setup used by Jones et al.34 who increased
concentrations of TMP for reaction on thymidine by reason that this
might be a better model for the intrastrand reaction likely taking
place on oligonucleotides, 10 equiv excess of TMP was used here.
However, employing a mixture of 1 and 5 in the same setup (exp.
no. 13) afforded approximately 80% methylated furyl compound 4,
and 20% 3, while no starting material 5 was left. Moreover, besides
of remaining uridine 1, material identiﬁed as N-methyl uridine 2,
could be monitored indicating methylation of uridine 1, too, in
approximately 30% (Fig. 3). All peaks were assigned via retention
time of reference compounds, and additionally collected and ana-
lyzed by mass spectrometry.2.3. Mechanistic considerations
All our results indicate that methylated uridine species 2 and 4
formed under particular conditions. Interestingly, the extent of
methylation was found to be rather different for unmodiﬁed uri-
dine (methylation degree in ON 3 approximately 8%, in monomer
test, exp. no. 13, less than 30%) compared to 5-furyl uridine
(methylation degree in ON 3 almost 50%, in monomer test, exp. no.
13, approximately 80%). This difference in reactivity towards
methylation might be due to the fact that nucleophilic attack of N3
of the uridine derivative is favored if the acidity of N3 is higher. In
fact, the calculated pKa value for uridine is 9.40.1 while it is de-
creased to 8.90.1 for 5-furyl uridine (calculated by ACD Persepta
1997e2012). This is in full agreement to the electron-withdrawing
character of the furyl substituent stabilizing negative charge that
results from deprotonation. Furthermore, we assume that the large
excess of palladium catalyst and eventually ligand might lead to
complexation of the nucleoside providing further stabilization of
the deprotonated, nucleophilic uridine derivative. Particularly co-
ordination of the metal between carbonyl in 6-position and a fur-
ther oxygen, such as 1-O of furyl in compound 3, forms a six-
membered complex, which is energetically favored and stable.
These effects based on the furyl substituent in 3 do not exist for
unmodiﬁed uridine 1, which is not surprisingly less reactive.
Additionally, we observed that a single uridine alone has not
been methylated under Stille conditions but presence of 5-iodo
uridine was required to initiate the catalytic cycle. Control tests
Fig. 3. RP HPLC chromatogram: methylation test on uridine 1 and 5-iodo uridine 5 under Stille cross-coupling conditions of RNA and addition of TMP mimicking the protected
phosphate backbone (compare Table 2, exp. no. 13).
Table 2
Monomer test reactions to investigate methylation process mimicking conditions of
Stille cross-coupling on RNA by addition of TMPa
Exp. no. Start. mat. Fur-Sn(Bu)3 TMP Result
1b U (1) þ 1 equiv No transformation
2b U (1) d 1 equiv No transformation
3b 5-IU (5) þ 1 equiv Traces of Me-Fur-U (4)
4b 5-IU (5) d 1 equiv No transformation
5c U (1) þ 1 equiv No transformation
6c U (1) d 1 equiv No transformation
7c 5-IU (5) þ 1 equiv 35% Fur-U (3)
65% Me-Fur-U (4)
8c 5-IU (5) d 1 equiv No transformation
9c,d U (5) þ 1 equiv No transformation
10c,d 5-IU (5) þ 1 equiv 2 min: >90% Fur-U (3);
20 h: 20% Me-Fur-U (4)




12c U (1) þ 10 equiv No transformation




a Setup under particular conditions was based on standard Stille cross-couplings;
reaction times were between 13 h and 24 h; analytical samples were quenched with
water/acetonitrile, diluted, and subjected to analytical RP HPLC; ratios given in this
table were determined via peak integration.
b Reaction was carried out at room temperature.
c Reaction was carried out at 60 C.
d Increased loading of 1.2 equiv Pd2(dba)3 as catalyst and 2.6 equiv P(furyl)3 as
ligand were used to simulate high excess used for Stille cross-couplings on RNA.
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whether an intermediate or rather side-product, such as tributyltin
iodide that forms during catalytic cycle could play a role in mech-
anism of methyl group transfer. For that purpose, several experi-
ments utilizing tributyltin iodide instead of tributylorganostannane
and with or without catalyst/ligand were performed with uridine,
5-iodo uridine, a mixture of both or 5-furyl uridine. Particularly,
test reactions with 5-furyl uridine (shown to be most reactive to-
wards methylation due to electronic reasons, compare to results
above) treated with Pd2(dba)3, P(furyl)3, TMP, and SnBu3I revealed
an outcome ﬁtting well to our hypothesis. N-Me-5-furyl uridine 4was detected in analytical RP HPLC and additionally assigned by
mass spectrometry.
Hence, results so far indicate involvement of tributyltin iodide to
mediate methylation process as mechanistic explanation, but need
to be further investigated to provide deﬁnite prove.2.4. Remarks and further studies on ACE protected RNA
It must be noted that the foregoing considerations about meth-
ylation processes only concerned methyl phosphate protected RNA
containing uridine. The effect and very clear indication of signiﬁcant
amounts of several methylated species were due to use of a poly
uridine sequence, such asON 3; and additionally, due to presence of
5-furyl uridine beingmore prone to deprotonation and nucleophilic
attack towards electrophiles. In comparison, for poly adenosine,
none, and for mixed sequences containing merely few uridines and
2-furyl adenosine (providing no NH in the ring system) instead of 5-
furyl uridine as modiﬁed building block, only traces of methylated
side product were observed6 in high-resolution mass spectra if
prepared via ACE chemistry. However, it was proven and further
elucidated within this work that ACE chemistry using methyl pro-
tection on phosphorus provides a signiﬁcant drawback if Stille
cross-coupling is applied on uridine-rich sequences.
Moreover, we aimed to check a further setup to prevent the
problem of methylation occurring on methyl phosphate protected
RNA. Conditions of Stille coupling obviously promotemethyl group
transfer, and hence we planned to convert the order of Stille de-
rivatization and methyl group removal to carry out Stille couplingon RNA already lackingmethyl groups. Sincemethyl group removal
is a step employed independently from basic deprotection (that
removes base protecting groups and releases RNA from solid sup-
port), methyl groups were removed prior to Stille coupling, which
was subsequently performed on RNA with deprotected phosphate
backbone but still bound on solid support, and ﬁnally the oligo-
nucleotide ON 5 was subjected to basic deprotection. Un-
fortunately, no intact ON 5 could be detected by HPLC and mass
spectrometry but only truncated sequences could be isolated.
Thus, Stille cross-coupling seems to be not compatible with RNA
being deprotected on the phosphate backbone.
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In conclusion, we studied the impact of selecting an appropriate
protecting group strategy qualiﬁed for postsynthetic modiﬁcation
on RNAwith respect to product formation, emerging side reactions
and yields. Observed side-products arising on methyl phosphate
protected poly uridine RNA under Stille cross-coupling conditions
proved to be N-methylated material caused by methyl group
transfer from the methyl protected phosphatetriester backbone.
We investigated this phenomenon by enzymatic degradation of
RNA, and subsequently identiﬁed and characterized resulting
monomer building blocks. We performed monomer model re-
actions with TMP mimicking Stille conditions on RNA, which elu-
cidated the methylation processes and role of methyl instead of
cyanoethyl as phosphate protecting group in ACE chemistry. We
discovered and explained that presence of Stille coupling condi-
tions considerably increases the methylation activity.
Overall, we could demonstrate that TBDMS-protected RNA and
newly developed TC chemistry are both equally qualiﬁed for post-
syntheticderivatizationbyStille coupling,while evenhighercoupling
efﬁciency in automated oligonucleotide synthesis was achieved via
TC strategy. In contrast, applicability of the otherwise very advanta-
geousdsince being mild and high yielding in RNA synthesisdACE
strategy is limited in postsynthetic Stille cross-coupling involving
uridines, particularly carrying electron-withdrawing groups, due to
methyl migration resulting in methylated side-products.
4. Experimental section
4.1. General information
All reagents were purchased from Aldrich or Alfa Aesar and
were used as received.
CAUTION: Organo(tributyl)tin reagents and trimethylphosphate
are hazardous compounds and can harm health via inhalation, skin
contact and ingestion.
NMR spectra were recorded on Bruker AV instruments at
300 MHz and 300 K. Chemical shifts (d) are reported in parts per
million relative to the solvent signal. The ﬁne structure of proton
signals was speciﬁed with s (singlet), d (doublet), t (triplet), q
(quartet), m (multiplet), dd (doublet of doublet), dt (doublet of
triplet), bs (broad singlet).
Thin layer chromatograms (TLC) were recorded on 60 F254 plates
from Merck (thickness of layer 0.2 mm). Column chromatography
was carried out on silica gel 60 (40e63 mm, Merck).
Reversed Phase (RP) HPLC was performed on a Jasco LC-
2000Plus HPLC system equipped with a Jasco UV 2075Plus de-
tector (detection at 254 nm).
ESI-Mass spectrometry was performed on a Fisons instrument
equipped with a VG platform II with quadrupol analyser or on
a Nano-ESI Mariner Biospectrometry Workstation from PerSeptive
Biosystems.
High-resolution mass spectra (HRMS) were measured on
a MALDI Orbitrap LTQ XL instrument (Thermo Fisher).
RNAs ON 1eON 4 were synthesized via ACE, TBDMS, or TC
strategy, postsynthetically modiﬁed, deprotected, puriﬁed, and
characterized as described before.6 ON 5 was subjected to same
procedures but with the difference of converted order in methyl
deprotection and postsynthetic modiﬁcation: methyl groups were
removed directly after RNA synthesis, subsequently Stille coupling
was performed, and ﬁnally basic deprotection and cleavage from
solid support was carried out.
N-methyl uridine 2 as reference compound has been prepared in
analogy to methylation of thymidine reported by Jones et al.34 Mass
spectrometry after separation on RP HPLC showed a signal in full
agreement with literature.35 Analytical reversed phase HPLC afterenzyme digestion and to monitor monomer model reactions was
performed on an analytical (2504.6 mm) Phenomenex C12 col-
umn [gradient: A: 1M TEAA (triethylammonium acetate) buffer, pH
6.5; B: Millipore water, C: acetonitrile; constant 10% A, 0e20 min:
3e15% C and 20e21 min: 15e18% C, 21e23 min: 18% C, 23e25 min:
18e80% C, 25e30 min: 80e3% C; 1 mL/min ﬂow].
4.2. General procedure for enzymatic digestion21
Typically 4 nmol RNA was dissolved in 100 mL acetate buffer
(30 mM sodium acetate, pH adjustment to 5.4 by acetic acid) and
25 mL (300 units/mL) Nuclease P1 (from Penicillium citrinum, Sig-
maeAldrich) was added. The mixture was incubated for 2 h at 37 C
and afterward 40 mL dephosphorylation buffer (0.5 M TriseHCl and
1 mM EDTA, pH adjustment to 8.5 by HCl) and 1 mL (10 units) al-
kaline phosphatase (from calf intestine, SigmaeAldrich) were
added. After incubation for another 2 h at 37 C, the mixture was
directly injected to analytical RP HPLC.
4.3. General procedure for methylation test reactions on
monomers
Model reactions on uridine 1 and 5-iodo uridine 5 were based
on common handling and proceeding for Stille cross-couplings on
monomers and RNAwith tributylfuryl stannane as described before
(typically 25 mg or 50 mg nucleoside, 0.054 equiv Pd2(dba)3/
0.12 equiv P(fur)3, 1.1 equiv tributylfuryl stannane in 1 mL abs. DMF,
60 C, 13e24 h)6 with the difference that trimethylphosphate was
added in all casesdparticular conditions and changed parameters
are presented in Table 2. Experiments were controlled by RP HPLC
to monitor conversion products, and besides assignment of com-
pounds 1e4 via comparison by retention times of reference chro-
matograms, peaks of all four compounds were collected and
additionally analyzed by mass spectrometry.
The new compound N-methyl-5-furyl uridine (4) formed in
several experiments, and was analyzed by mass spectrometry, but
was supplementary worked-up, isolated, and puriﬁed in case of
exp. no. 7 (Table 2).
4.3.1. N-methyl-5-furyl uridine (4). The reaction was carried out
with 50 mg (0.135 mmol) 5-iodo uridine 5 under conditions de-
scribed above. After stirring for 20 h, the concentrated reaction
mixture was puriﬁed by column chromatography (eluent 9:1 DCM/
MeOH) to yield 15 mg (0.048 mmol) to give 5-furyl uridine 3 (ex-
pected and common product in particular Stille cross-coupling,
analytical data in full agreement to those already reported6) and
25 mg (0.077 mmol) N-methyl 5-furyl uridine 4 as off-white solid.
Rf¼0.46 (9:1 DCM/MeOH);
1H NMR: d [ppm] (300 MHz, DMSO-d6): 3.25 (3H, s, N-CH3),
3.58e3.64 (1H, m, 50-CH), 3.69e3.75 (1H, m, 50-CH), 3.91e3.94 (1H,
m, 40-CH), 4.03 (1H, q, J¼5.0 Hz, 30-CH), 4.12 (1H, q, J¼4.9 Hz, 20-CH),
5.10 (1H, d, J¼5.4 Hz, 30-OH), 5.22 (1H, t, J¼4.6 Hz, 50-OH), 5.43 (1H,
d, J¼5.4 Hz, 20-OH), 5.90 (1H, d, J¼4.5 Hz, 10-CH), 6.53 (1H, dd, J¼1.8
and 3.3 Hz, furyl-H400), 6.91 (1H, dd, J¼3.1 Hz, J¼0.7 Hz, furyl-H300),
7.61 (1H, dd, J¼1.8 Hz, J¼0.8 Hz, furyl-H500), 8.53 (1H, s, 6-CH);
13C NMR: d [ppm] (75 MHz, DMSO-d6): 27.61 (N-CH3), 60.23 (50-
CH2), 69.43 (30-CH), 74.12 (20-CH), 84.70 (40-CH), 89.39 (10-CH),104.65
(5-C-furyl), 107.87 (furyl-C300), 111.48 (furyl-C400), 134.34 (6-CH),
141.53 (furyl-C500), 146.48 (furyl-C200), 149.79 (2-CO), 159.19 (4-CO);
ESI()-MS: calcd: 324.10, found (m/z): 323.1 [MH], 359.2
[MþCl];
HRMS (MþNa): calcd 347.08497, found: 347.08525.
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